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Abstract: The genus Streptomyces produces secondary metabolic compounds that are rich in
biological activity. Many of these compounds are genetically encoded by large secondary metabolism
biosynthetic gene clusters (smBGCs) such as polyketide synthases (PKS) and non-ribosomal peptide
synthetases (NRPS) which are modular and can be highly repetitive. Due to the repeats, these gene
clusters can be difficult to resolve using short read next generation datasets and are often quite
poorly predicted using standard approaches. We have sequenced the genomes of 13 Streptomyces spp.
strains isolated from shallow water and deep-sea sponges that display antimicrobial activities against
a number of clinically relevant bacterial and yeast species. Draft genomes have been assembled
and smBGCs have been identified using the antiSMASH (antibiotics and Secondary Metabolite
Analysis Shell) web platform. We have compared the smBGCs amongst strains in the search for novel
sequences conferring the potential to produce novel bioactive secondary metabolites. The strains
in this study recruit to four distinct clades within the genus Streptomyces. The marine strains host
abundant smBGCs which encode polyketides, NRPS, siderophores, bacteriocins and lantipeptides.
The deep-sea strains appear to be enriched with gene clusters encoding NRPS. Marine adaptations
are evident in the sponge-derived strains which are enriched for genes involved in the biosynthesis
and transport of compatible solutes and for heat-shock proteins. Streptomyces spp. from marine
environments are a promising source of novel bioactive secondary metabolites as the abundance and
diversity of smBGCs show high degrees of novelty. Sponge derived Streptomyces spp. isolates appear
to display genomic adaptations to marine living when compared to terrestrial strains.
Keywords: marine Streptomyces; biosynthetic gene clusters; secondary metabolites
1. Introduction
Microbially derived natural products are an important source of novel biotherapeutic agents,
with more than 22,000 biologically active compounds being isolated to date from microorganisms [1].
Approximately 45% of these are produced by Actinobacteria, with members of the genus Streptomyces
being particularly proficient producers [2]. Actinomycetes have produced a number of important drug
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leads which have subsequently been developed into immunosuppressive (rapamycin), anti-cancer
(bleomycin, daunorubicin, mitomycin) and anti-microbial (amphotericin B, erythromycin, vancomycin)
drugs. However, there is an ongoing need for novel bioactive compounds, particularly antibiotics,
due to the emergence of antibiotic resistance in clinically important bacterial pathogens [3]. The rapid
dissemination of antibiotic resistances has coincided with the antibiotic “discovery void” where no
new antibiotic scaffolds have been identified since 1987 [4].
Strategies to address the dearth of newly identified clinical therapeutics have progressed through
extensive screening regimes of environmental microbial isolates [5], through the dawn of metagenomics
where environmental DNA was cloned to heterologous expression hosts [6]. This promised to allow
access to the genetic repertoires of uncultivable microbes but resulted in the “great screen anomaly” [7]
where gene and product discovery from clone libraries is disappointingly low compared to what
might have been expected. The trend has now returned to investigating cultivable isolates, armed with
powerful genome sequencing technologies which have made huge numbers of draft and completely
resolved bacterial genomes available for “genome mining”. The somewhat surprising outcome of these
efforts is that the genomes of, for example, Actinobacteria contain dozens of secondary metabolism
biosynthetic gene clusters (smBGCs), the majority of which appear to be “silent” or “cryptic” [8].
This discovery led to the estimate that no more than 10% of the genes encoding small molecules
in bacteria have to date been identified and furthermore that a single gene cluster can give rise to
a suite of related compounds which can act synergistically to inhibit bacterial growth [9]. Further
conservative estimates derived from genome sequence data suggest that the genus Streptomyces alone
may be capable of producing 150,000 secondary metabolites with fewer than 5% of these having been
characterized to date [10].
These findings have focused efforts to attempt to activate these silent clusters through imaginative
approaches such as OSMAC (one strain many compounds) cultivation efforts, co-cultivation of
microbes to provide environmental cues or stresses, using genome data to ‘awaken’ gene cluster
activators, to delete suppressors or to engineer strong promoters upstream of BGCs of interest [11].
A high-throughput approach, termed high-throughput elicitor screens (HiTES), has been developed
where reporter genes such as lacZ or GFP are cloned into a BGC of interest and the strain is exposed to
libraries of small compound potential ‘elicitors’ such as sub-inhibitory concentrations of antibiotics [12].
The elegance of this approach is that endogenous regulation of gene expression is maintained,
the reporter genes allow the identification of the previously silent clusters, the gene cluster activator
is identified, and the small molecule gene cluster product is also identified. This approach allowed
Xu and colleagues to identify two cytotoxins as inducers of BGCs in Streptomyces albus J1074, and to
characterize 14 novel small molecule products, one of which is a novel antifungal and another which
may find use as an anti-cancer agent [13].
Genome mining of terrestrial actinomycete bacteria has proven to be useful in the identification
of secondary metabolism biosynthetic gene clusters (smBGCs) such as those encoding the bottromycin,
planosporicin and tunicamycin clusters [14] and it is clear that based on the successful genome
mining on the Salinispora genus, which resulted in the identification of a number of novel biosynthetic
gene clusters [15], and the recent work on the anthracimycin gene cluster from the marine derived
Streptomyces sp. T676 [16] amongst others, that genome mining may also prove effective in the
identification of potentially novel chemistry from other marine derived actinomycete bacteria.
Marine derived actinomycetes are known to produce a broad range of structurally complex
secondary metabolites with broad biological activities, and they are a source of an ever increasing
number of natural products [17,18]. Novel Actinomycetes, including novel Streptomycetes, have also
been isolated from deep-sea environments. The deep-sea is a harsh environment with high
pressures, low temperatures, high salinity and low light and oxygen concentrations [19]. Interestingly,
Streptomycete-derived novel bioactive secondary metabolites have been identified from isolates from
the deep-sea [19]. Antibacterial and cytotoxic metabolites, are produced from a type I PKS gene cluster
by Streptomyces sp. SCSIO 01127 which was isolated from a depth of 1350 m in the South China Sea [20]
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while antibacterial compounds, are produced by Streptomyces scopuliridis SCSIO ZJ46 which was
isolated from a depth of 3536 m in the South China Sea [21]. Streptomyces drowzdowiczii SCSIO 10141,
isolated from 1396 m in the South China Sea is known to produce the anti-infective metabolites [22];
cytotoxic and antibacterial compounds are produced by another deep sea isolate, Streptomyces niveus
SCSIO 3406 [23].
With this in mind and following an extensive screening regime of marine actinomycete bacteria
which we had previously isolated from the shallow water sponge Haliclona simulans [24] and
from two deep-sea sponges Lissodendoryx diversichela and Stelletta normanii [25], involving growth
inhibition of a number of clinically relevant bacterial and fungal species, 13 marine sponge-derived
Streptomyces spp. strains were chosen for whole genome sequencing in an attempt to determine the
secondary metabolite biosynthetic potential of these strains.
2. Results and Discussion
2.1. Antimicrobial Activities
A total of over 540 actinomycetes, including some which had previously been isolated
from shallow water and deep-sea sponges in Irish waters [24–26], were screened for growth
inhibition of a number of clinically relevant bacterial and fungal/yeast species. Thirteen of
these strains which displayed the most interesting range of bioactive antimicrobial activities,
including growth inhibition of problematic anti-microbial resistant (AMR) human pathogens such as
methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-intermediate Staphylococcus aureus
(ViSA), were identified for subsequent analysis (Table 1).
Table 1. Antimicrobial activities of cultured sponge bacteria using deferred antagonism assays.
1 Bacillus cereus FPL1; 2 Bacillus subtilis 1A40; 3 B. subtilis 1E32; a hVISA (Heterogonous Vancomycin
Intermediate Staphylococcus aureus) 22900; b MRSA (Methicillin resistant S. aureus) ST544; C VISA
(Vancomycin intermediate S. aureus) 35403; d S. aureus NCIMB 9518: ‘+’ = positive. ‘−’ = negative; n.d.
not determined. * adapted from Kennedy et al., 2009 [19].
Test Strain
Gram Negative Bacteria Gram Positive Bacteria Yeasts
E. coli
NCIMB 12210
P. aeruginosa
PAO1
Bacillus
pp.
Staphylococcus
spp.
L. monocyte
genes F2365
Candida
spp.
A. fumigatus
ATCC 46645
SM1 * + − + 1,2 + a + + n.d.
SM5 * + − + 1,2 + a − − n.d.
SM9 * + − − − − − n.d.
SM10 * + n.d. − − − − n.d.
SM11 * − − + 2 + a,b − − n.d.
SM12 * − + − + a − − n.d.
SM14 * − − + 1,2 + a − − n.d.
SM16 * − + + 2 + c − − n.d.
SM17 * + − − + b − + n.d.
SM18 * − − + 2 + b − − n.d.
FMC008 * − + + 2 + d − − n.d.
B226SN101 − − − 3 − n.d. + +
B188M101 − − − 3 − n.d. + +
2.2. Genome Sequencing
The genomes of these 13 Streptomyces spp. were sequenced using Illumina MiSeq paired-end
sequencing. These strains were designated as follows: SM1, SM5, SM9, SM10, SM11, SM12, SM14,
SM16, SM17, SM18, FMC008 isolated from shallow water sponges and B188M101 and B226SN101,
isolated from deep-sea sponges. Genome assemblies resulted in a large number of contigs (n = 195–1592)
(Table 2). Gap closure of these assemblies was hampered by the typical high GC content of the
genomes of Streptomyces spp., as well as the presence of very many highly repetitive sequences in gene
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clusters such as polyketide synthase (PKS) and nonribosomal peptide synthetases (NRPS) clusters.
The genomes ranged in size from 6.41 to 8.44 Mb (Table 2).
Table 2. No. of contigs and total genome size of marine Streptomyces spp. isolates.
Isolate ID No. of Contigs Total Length (Mb)
B188SM101 609 8.23
B226SN101 580 8.39
SM5 469 7.62
SM10 195 7.48
SM11 311 8
SM12 910 6.5
SM16 388 8.44
SM1 1057 8.08
SM9 1592 6.47
FMC008 1369 6.5
SM18 403 7.6
SM14 639 6.41
SM17 674 7.106
2.3. Taxonomy and Phylogeny
The phylogeny of the 13 marine Streptomyces was determined by analysis of the 16S rRNA genes
(Figure 1A), and by Feature Frequency Profile (Ffp) [27] of the whole genomes (Figure 1B), together
with genomic analysis using Kraken (Supplementary Table S1) [28]. In the latter analysis, greater than
75% of the sequence reads were assigned closely to a known species while three of the strains (SM1,
SM12 and SM14) could only be assigned at the genus level (Table 3).
The strains recruited to four main groups, Group A (comprising S. griseus, S. fulvissimus as well as
SM11 and SM16 and both of the deep sea strains, B188M101 and B226SN101), Group B (comprising
S. albus, SM17, SM9 and FMC008), Group C (comprising S. sirex, SM18, SM5 and SM10) and Group D
(comprising SM12 and SM14) (Figure 1B). Analysis of the 16S rRNA genes suggest that SM1 is closely
related to the group D isolates in a polyphyletic clade which is a sister clade to the Group B isolates,
however Ffp based phylogeny indicates that SM1 falls outside of that polyphyletic clade.
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2.4. Pan Genome and Core Genome
The pan genome (Figure 2A) of these marine isolates is open with an average of 648 genes added
for each additional genome considered and a total gene complement of 14,066 genes shared amongst
the isolates. The core genome (Figure 2B) comprises 1699 genes indicating that only 12% of the pan
genome is shared by all of the strains examined here. The pan genome analysis highlights the genetic
diversity within the genus, indicating that the biosynthetic potential of these marine Streptomyces
warrants further investigation, including the potential for biodiscovery of novel secondary metabolites
from these isolates.
The highest intra-group sequence conservation, and therefore the lowest diversity, was seen within
the Streptomyces albus group (Group B—SM9, SM17 and FMC008), suggesting that this group may
prove to be less interesting in terms of potential discovery of novel bioactive secondary metabolites.
While this hypothesis is supported by antiSMASH [29], analyses of the genomes of strains SM9
and FMC008 (which noticeably harbours the lowest abundance of smBGCs of any of the strains in
this study—16 and 15 clusters, respectively) but not when considering the genome of strain SM17
(comprising 49 secondary metabolism gene clusters—the fourth highest abundance of any of the
strains in this study).
2.5. Secondary Metabolism Biosynthetic Gene Clusters
The 13 Streptomyces spp. genomes were investigated for the presence of smBGCs of potential
interest. All of the genomes examined contained numerous smBGCs as identified by antiSMASH
(Table 3; Supplementary Tables S2–S14). The 13 strains contain a combined total of 485 individual
clusters which share homology to 87 distinct known gene clusters whose metabolic product is known.
While some clusters were common to many strains, all strains also contained clusters unique to
that strain only (48 gene clusters are found in only one strain). The most commonly shared clusters
were those showing similarities to the known clusters which produce the compatible solute ectoine
(11 strains), the siderophore desferrioxamine B and the anti-tumour metabolite herboxidiene (7 strains),
the peptide siderophore coelichelin, the carotenoid light-harvesting pigment isorenieratene and the
terpene hopene (6 strains). The abundances or types of particular smBGCs are not a clear indicator of
phylogenetic relatedness or of the isolation source (host sponge or sampling depth).
Mar. Drugs 2017, 15, x    6 of 18 
 
2.4. Pan Genome and Core Genome 
The pan geno e (Figure 2A) of these  arine isolates is open  ith an average of 648 genes added 
for each additional geno e considered and a total gene co ple ent of 14,066 genes shared a ongst 
the isolates. The core geno e (Figure 2B) co prises 1699 genes indicating that only 12  of the pan 
geno e is shared by all of the strains exa ined here. The pan geno e analysis highlights the genetic 
diversity  ithin  the genus,  indicating  that  the biosynthetic potential of  these  arine Streptomyces 
arrants  further  investigation,  including  the  potential  for  biodiscovery  of  novel  secondary 
metabolites from these isolates.   
The highest  intra‐group sequence conservation, and  therefore  the  lowest diversity, was  seen 
within the Streptomyces albus group (Group B—S 9, SM17 and FMC008), suggesting that this group 
may  prove  to  be  less  interesting  in  terms  of  potential  discovery  of  novel  bioactive  secondary 
metabolites. While  this hypothesis  is  supported by  antiSMASH  [29],  analyses of  the genomes of 
strains SM9 and FMC008 (which noticeably harbours the lowest abundance of smBGCs of any of the 
strains in this study—16 and 15 clusters, respectively) but not when considering the genome of strain 
SM17 (comprising 49 secondary metabolism gene clusters—the fourth highest abundance of any of 
the strains in this study). 
           
        s    i t                
                    fi      
  ;                           
            i i      cl st r   s   eta li   r t is kno n. 
   clusters were common to many strains, all strains also c ntai ed cluster  uniq e to that 
strain only (48 gene clusters are found in only  e strain). The most comm nly shared clusters w e 
those showing similarities  to  the know  clusters which produce  the compatible solute ectoine  (11 
strains), the siderophore desf rrioxamine B and the anti‐tumour metabolite herboxidiene (7 strai s), 
            ‐          
                                 
             ( t s   r s li   e t ). 
 
Figure 2. (A) Pangenome and (B) core genome of Streptomyces spp. marine isolates. i r . ( ) ( ) r f tre t ces s . ri is l t s.
Mar. Drugs 2018, 16, 67 7 of 18
Group A isolates display the largest genome sizes (Table 1) and with the exception of SM16
(n = 39) also possess the most abundant smBGCs (n = 51–54). The genomes of the Group A isolates
show many similarities with all strains harbouring gene clusters related to the known clusters which
produce the previously characterised metabolites ectoine, desferrioxamine B, coelichelin, herboxidiene
and isorenieratene and also for γ-butyrolactone, alkylresorcinol and griseobactin. While these latter
three metabolites are shared by all Group A strains, they are also exclusive to that group. Three of the
four Group A strains also harbour gene clusters with similarities to the cluster known to produce the
antibiotic friulimicin produced by the actinomycete Actinoplanes friuliensis, daptomycin, the heat-stable
antifungal factor (HSAF) and also the peptide morphogen AmfS.
Gene clusters unique to one Group A isolate include those related to the production of thaxtomin,
skyllamycin, balhimycin, griseoviridin, kanamycin, surfactin, myxothiazol A, pristinamycin,
streptolydigin, concanamycin, chartreusin, naringenin, platensimycin, kosinostatin, oxazolomycin,
bacillibactin, neocarzinostatin, glycolipopeptide, guadinomine and borrelidin.
Despite the phylogenetic relatedness of Group A isolates, the bioactivity profiles of the strains
were not consistent. The deep-sea strains (B188M101, B226SN101) only displayed activity against yeasts
while those sourced from shallow waters were only active against bacteria. Both Group A shallow
water isolates (SM11, SM16) inhibited the growth of problematic drug resistant Staphylococcus spp.
(Table 1). This makes further investigation of the smBGCs of these strains of high interest.
Groups B, C and D strains are less similar with few gene clusters shared by all members of any of
those groups, except for ectoine biosynthesis genes which are highly similar in all Group B and Group
C strains.
Two of the Group B strains (SM9, FMC008) harbour the fewest smBGCs (Table 3) in this study
while the genome of the other Group B strain (SM17) is noticeably enriched in NRPS gene clusters.
Analysis by antiSMASH shows that 15 of the 18 NRPS clusters in the SM17 genome show no
similarities to known NRPS gene clusters. Analysis of Pfam domains of these clusters condensation
(Supplementary Figures S1–S3) and epimerization domains (Supplementary Figure S5A) are diverse
and abundant and form clades which correlate closely with phylogeny and show high similarities
to those domains in the genome of S. albus J1074. All Group B strains harbour gene clusters with
low similarity to the antimycin production cluster from S. albus J1074. Two of the three Group B
strains also harbor clusters with low similarities to complestatin biosynthesis genes (SM9 and SM17)
from S. albus J1074, the desotamide production cluster (SM9 and FMC008) from Myxococcus fulvus
HW-1 and mannopeptimycin production genes (SM9 and FMC008) from Streptomyces hygroscopicus.
The abundance of unknown NRPS gene clusters in the genome of SM17 as well as its broad range of
antimicrobial activities versus E. coli and MRSA (Table 1) warrant further research efforts aimed at
identifying the encoded metabolites.
Two of the three Group C strains contain gene clusters showing relatedness to the clusters known
to produce mirubactin and paenibactin in Streptomyces sp. NTK 937, coelibactin in Streptomyces lividans
TK24 and bafilomycin in Streptomyces lohii strain ATCC BAA-1276 (SM5 and SM18), together with
cystothiazol A in Streptomyces griseus subsp. griseus NBRC 13350 and steffimycin in Streptomyces
fulvissimus DSM 40593 (SM10 and SM18). This group contains numerous PKS, NRPS and PKS/NRPS
hybrid clusters and display antibiotic activity against E. coli (SM5 and SM10) and against hVISA (SM10)
and MRSA (SM18) while also inhibiting the growth of Bacillus spp. (Table 1). Thirteen of the smBGCs
in the genome of SM18, including PKS, NRPS, PKS/NRPS hybrid, lantipeptide and bacteriocin clusters
show no relatedness to known clusters in antiSMASH analysis.
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Table 3. Numbers of secondary metabolism gene clusters in the genomes of marine Streptomyces spp. isolates. * Numbers of PKS “types” (I, II & III) can be seen in
Supplementary Tables S2–S14.
Isolate ID PKS * NRPS PKS/NRPS Hybrid Bacteriocin Lantipeptide Siderophore Terpene Butyrolactone Ectoine Other TOTAL
B188M101 4 19 4 2 4 2 5 2 2 9 53
B226SN101 2 20 4 2 3 2 5 2 2 9 51
SM5 5 9 5 2 1 1 6 1 1 7 38
SM10 16 3 3 5 3 2 4 2 1 5 44
SM11 10 11 5 2 3 2 6 2 2 11 54
SM12 18 7 - 1 3 4 1 1 1 4 40
SM16 2 5 6 1 5 2 7 2 2 7 39
SM1 4 8 1 2 2 2 4 1 - 5 28
SM9 3 2 - 1 - 2 6 - 1 1 16
FMC008 1 3 - 1 - 1 5 - 1 3 15
SM18 9 9 6 2 2 1 6 1 1 4 41
SM14 8 2 - - 1 2 - 1 - 3 17
SM17 14 18 2 3 2 3 5 - 1 1 49
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The only secondary metabolism gene cluster common to Group D isolates displays low levels
of similarity to the cluster which produces zorbamycin in Streptomyces flavoviridis ATCC 21892.
Both Group D strains (SM12 and SM14) inhibited the growth of hVISA (Table 1) making them of
particular interest because they appear phylogenetically distant from all other strains presented
here. The strains could not be assigned to a genus in Kraken analysis (Supplementary Table S1) and
appear phylogenetically distant in FFP analysis (Figure 1B). The genome of SM12 hosts 18 Type
I PKS clusters of which 10 share no homology with known gene clusters in the linked Minimum
Information about a Biosynthetic Gene Cluster (MIBiG) database (https://mibig.secondarymetabolites.
org/index.html) [30]. Increasing the taxonomic diversity of available Streptomyces spp. strains
available for screening regimes is predicted to increase the chemical diversity of identified metabolites.
With that in mind, these phylogenetically remote strains with demonstrated bioactivities and numerous
uncharacterised PKS gene cluster products are of high interest.
The genome of SM1, which does not recruit to the groups (A–D) described here, also harbours
a unique secondary metabolism gene cluster profile. While SM1 does harbour clusters for the frequently
observed desferrioxamine B and isorenieratene production genes, it is one of only two genomes
presented here not to encode ectoine biosynthesis genes. Of the 28 gene clusters in the genome of SM1,
as identified by antiSMASH, only nine of those clusters show homology to known gene clusters and
three of these are unique to SM1 in our study. As this strain has displayed broad-range antimicrobial
activity and appears only distantly related to other strains in Figure 1B and distantly related to the
metabolically talented S. coelicolor A3(2) in Kraken analysis (Supplementary Table S1), it also warrants
further investigation with respect to the further characterization of its metabolites.
2.6. Protein Family (Pfam) Domain Analysis
The genome assemblies of the 13 marine Streptomyces strains were highly fragmented, and so
smBGC prediction can be hampered by particular clusters being fragmented across different contigs.
This can lead to an over-prediction of the numbers of clusters present. Nonetheless it was possible to
analyse deduced proteins at the domain level. Translated sequences of protein domains of interest:
ketosynthase (KS) domains of PKS genes (Supplementary Figure S1), condensation starter domains
(Supplementary Figure S2), condensation DCL domains (Supplementary Figure S3), condensation LCL
domains (Supplementary Figure S4) epimerization (Supplementary Figure S5A) and heterocyclization
(Supplementary Figure S5B) domains of NRPS gene clusters, IucA-IucC domains of siderophore genes
(Supplementary Figure S6), DUF692 domains of bacteriocin genes (Supplementary Figure S7) and LanC
domains of lantibiotic genes (Supplementary Figure S8) were extracted from the antiSMASH results
using a custom script. These domains were analysed and are presented as a heat-map (Figure 3) with
the evolutionary relationships of these protein domains shown in phylogenetic trees (Supplementary
Figures S1–S8).
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phylogenetic clades harbour sequences which correlate with the taxonomic phylogeny described in 
Figure 3. Log2 heat ap of predicted secondary etabolis protein do ains of interest fro arine
Streptomyces spp. isolates and from select reference terrestrial genomes.
2.6.1. S o ains of P S ene Clusters
f 25 KS domain sub-clades identified (Supplem ntary Figure S1), 12 of these clades include only
one of the phylogenetic sub-groups (A–D) described earli r (Figure 1B), suggesting a link between
th phylogeny of the isolates and a subset of the KS domains therein. As th remaining 13 clades of
KS omains contain domains fro two or ore phylogenetic subgroups, it appears hat these KS
domains are not phylogeny-re ated but represen a mor general genetic div rsi y. It is clear from the
tree (Suppl mentary Figure S1) that the number of clad s and th individual branch lengths, indicate
that very igh levels of di r ity are apparent even wi hin a single protein domain type amongst
a limited number of isolates from thi single genus.
2.6.2. rps ene lusters
Protein do ains fro NRPS clusters (condensation starter, condensation DCL, condensation
L L, epi erizatio and heterocyclizati ere analysed individually by sequence align ents and
phylogenetic tree building (Supple entary Figures S2–S5). Thirteen distinct clades of condensation
starter ai s ere bserved (Supplementary Figure S2). These domains appear diverse but
are more closely distinguishable as recruiting to phylogenetic groups A–D (Figure 1B) than is
observed in the KS domain analysis (Supplementary Figure S1). Six of the clades contain d ai s
from only one phylogenetic sub-gr up while one of these clades includes domains from all four
phylogenetic sub-groups. It is noted that a single isolate may contai m re than one condensation
starter domain gene (where more than one NRPS gene cluster is present). These condensation
starter domains may be highly similar (e.g., condensation starter domains of SM9— Suppleme tary
Figure S2) or indeed very different (e.g., condensation starter domains of SM12—Figure S2). It is also
noteworthy that although the genome of SM14 harbours two NRPS gene clusters, no condensation
starter omain has been identified in these clusters. W en considering other NRPS d mains,
condensation DCL (Supplementary Figure S3) and condensation LCL (Supplementary Figure S4),
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epimerization (Supplementary Figure S5A) and heterocyclization (Supplementary Figure S5B) domains,
many phylogenetic clades harbour sequences which correlate with the taxonomic phylogeny described
in Figure 1B. As before, no epimerization or heterocyclization domains were identified in the NRPS
clusters of Group D strains (SM12 and SM14). Nonetheless, even within the clades identified, noticeable
degrees of diversity are apparent (i) within strains with multiple gene clusters, (ii) within phylogenetic
clades and (iii) overall. The tree topologies and branch lengths indicate high levels of gene diversity in
marine Streptomyces spp. Group A isolates (SM11, SM16, B188M101 and B226SN101) appear enriched
for adenylation (Figure 3) and condensation (Supplementary Figures S2–S4) domains of NRPS gene
clusters when compared to the other phylogenetic sub-groups described here. There appears to be
a stronger link between taxonomic phylogeny and the evolutionary phylogeny of NRPS epimerization
(Supplementary Figure S5A) and NRPS heterocyclization domains (Supplementary Figure S5B).
These domains are highly abundant in Group A and Group B isolates but entirely absent from
the genomes of Group D strains. The majority of predicted protein domains from the deep sea isolates
(B188M101 and B226SN101) are more similar to each other than to similar genes in shallow water or
terrestrial isolates. This supports previous findings by our group where we reported putative deep sea
sponge specific microbiome [24] and secondary metabolome [31].
2.6.3. Siderophores, Bacteriocins and Lantibiotics
Phylogeny-related patterns of predicted protein domains of siderophores (IucA-IucC—
Supplementary Figure S6), bacteriocins (DUF692—Supplementary Figure S7) and lantipeptides
(LanC-like—Supplementary Figure S8) were notable with the majority of those domains identified
here, clustering more closely to domains from within the phylogenetic subgroups than to those of
other subgroups. Bioavailable iron in ocean waters has long been recognized as a limiting factor for
growth [32]. Dissolved iron concentrations are orders of magnitude higher in surface and mesopelagic
waters when compared to the deep sea [33]. Thus, it might be expected that microbes from deep waters
may contain more genes involved in iron chelation or with higher degrees of siderophore gene diversity.
We have not observed this however and possible explanations may be that the genes in the deep sea
strains are more highly transcribed than those of strains from shallower waters, or that the symbiotic
relationship between sponges and their resident microbiota may provide higher concentrations of
iron to the microbes than is available to planktonic ocean microorganisms. Iron has been identified as
an important mineral for sponge primmorph proliferation and morphogenesis [34] and it has been
demonstrated that some sponges can accumulate trace elements, including iron, at concentrations high
above those of seawater and sediments [35].
Eleven of the 13 genomes described here host DUF692 domains found in bacteriocin production
genes, the exceptions being SM9 and FMC008 despite antiSMASH predictions of one bacteriocin gene
cluster in each of those genomes. Conversely, the genome of SM14 hosts a DUF692 domain, but no
bacteriocin cluster was predicted for this strain by antiSMASH. Although five NRPS gene clusters
were predicted in the genome of SM10 by antiSMASH, only three DUF692 domains were identified.
Nonetheless, two of those domains are notably different to all other DUF692 domains identified
here and to each other. The genomes of all other strains host one DUF692 gene copy each. Degrees
of conservation in all deduced protein sequences apart from the aforementioned SM10 sequences
are evident from the phylogenetic tree (Supplementary Figure S7), though an evolutionary pattern
correlated with taxonomic phylogeny can also be seen.
When considering the lantibiotic (LanC-like) domains, Groups A (SM11, SM16, B188M101 and
B226SN101) and C (SM5, SM10 and SM18) as well as the terrestrial strains S. griseus and S. coelicolor,
hosted more potential LanC-like domains when compared to Groups B (SM9, SM17 and FMC008)
and D (SM12 and SM14) (Supplementary Figure S8). Strains B188M101 and SM16 hosted the most
lantibiotic smBGCs in this study (four and five respectively) and also hosted the most LanC-like
protein domain gene sequences (five and seven respectively). All seven of these protein domains on
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the SM16 genome are quite different to each other indicating that diverse lantipeptides may potentially
be produced by that strain.
2.7. Marine Adaptations
The 13 marine Streptomyces genomes were interrogated for the presence of genes that may
be potentially involved in the biosynthesis and/or transport of compatible solutes and other
osmoregulatory systems, which have previously been suggested to play a role in marine adaptation of
microorganisms [36]. The abundances of these genes were compared to abundances in the terrestrial
Streptomyces spp. genomes which were used to construct the Ffp phylogenetic tree (Figure 4).
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Figure 4. Marine adaptations in Streptomyces spp.: Abundances of compatible solutes and
osmoprotectant biosynthesis and/or transport genes and of CRISPR genes in the genomes of marine
Streptomyces spp. isolates (blue background) and reference terrestrial Streptomyces spp. genomes (orange
background). TRAP: Tripartite ATP-dependent Periplasmic transporters (organic acid import); BCCT:
Betaine Carnitine Choline Transporter; Trk: Potassium ion transport; TAT: Twin Arginine Translocator;
Rht: homoserine/threonine transport; steT: serine/ threonine exchanger transporter; LIV: Transport of
Branched-Chain Amino Acids; LctP: lactose permease; mscL: Large Conductance Mechanosensitive Ion
Channel; mscS: Small Conductance Mechanosensitive Ion Channel; PiT: Sodium-dependent phosphate
transporter; Mer: Mercury transporter; MIP: major intrinsic protein; TctA: Tripartite tricarboxylate
transporter; TctB: Tripartite tricarboxylate transporter; arsABCR: Arsenite detoxification system.
The marine isolates appear to be enriched for mercury and arsenic transport systems,
branched-chain amino acid transport (LIV), betaine and choline biosynthesis and heat shock proteins.
The marine strains appeared however to be deficient in sodium-proton antiporters, tripartite ATP
independent periplasmic transporters (TRAP), betaine transport (BCCT), serine/threonine export
(Rht), aquaporins (MIP) transport and cold shock proteins. It is interesting that the genomes of the
marine strains are enriched for the arsenic transport genes in light of the recent finding that sponge
associated Entotheonella spp. sequester arsenic in intracellular vesicles whilst residing in its sponge
host, Theonella swinhoei [37]. More work will be necessary to determine if the Streptomyces strains
described here are preferentially exporting arsenic or importing and sequestering it as a host-protection
symbiotic function. Our analysis also suggests that betaine may be the preferred compatible solute
amongst marine Streptomyces spp. as indicated by the higher abundances of betaine biosynthetic genes
when compared to those of ectoine or choline. This however needs to be experimentally confirmed by
assessing transcription rates of those genes.
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3. Materials and Methods
3.1. Sponge Sampling
The marine sponge Haliclona simulans (class Demospongiae, order Haplosclerida, family Chalinidae)
was sampled by SCUBA diving at a depth of 15 m in Kilkieran Bay, Galway, Ireland (N 53◦18′56.6′ ′,
W 09◦40′08.4′ ′) [24]. The sponge Lissodendoryx diversichela (class Demospongiae, order Poecilosclerida,
family Coelosphaeridae) was sampled using the ROV Holland I from the RV Celtic Explorer at a depth of
1350 m in the North Atlantic Ocean (N 54◦21′25.2′ ′, W 12◦14′49.9′ ′) off the west coast of Ireland [25].
The sponge Inflatella pellicula (class Demospongiae; order Poecilosclerida; suborder Myxillina; family
Coelosphaeridae) was sampled using the ROV Holland I at a depth of 2900 m in the North Atlantic Ocean
(N 54◦03′28.8′′, W 12◦32′53.5′′) [26].
3.2. Culture Isolation
Sponge samples were rinsed with sterile artificial seawater (3.33% Instant Ocean™—Aquatic
Eco-Systems Inc., Apopka, FL, USA) to remove exogenous materials. Sponge tissues (~1 g) were
macerated with a sterile razor blade. Serial dilutions of the macerated tissues were spread to
3 isolation media; (i) starch-yeast-peptone seawater agar (SYP-SW): 1% (w/v) starch, 0.4% (w/v)
yeast extract, 0.2% (w/v) peptone, 3.33% (w/v) artificial sea salts (Instant Ocean™), 1.5% (w/v) agar;
(ii) modified marine agar (MMA): 0.005% (w/v) yeast extract, 0.05% (w/v) tryptone, 0.01% (w/v)
β-glycerol phosphate disodium salt, pentahydrate, 3.33% (w/v) artificial sea salts (Instant Ocean™,
Apopka, FL, USA), 1.5% (w/v) agar and (iii) chitin agar: 4% (v/v) colloidal chitin, 1.5% (w/v) agar.
Culture plates were incubated at 28 ◦C for up to 8 weeks. Colonies were picked from isolation plates,
streaked to fresh agar plates to obtain pure, isolated colonies. Isolates were archived by growing in
liquid broth (SYP-SW) supplemented with 15% (v/v) glycerol and frozen at −80 ◦C.
3.3. DNA Extraction
Isolates were grown overnight (~16 h) in 5 mL liquid cultures. Cells were pelleted by centrifugation
(6000 g), supernatants were decanted and discarded. Cell pellets were resuspended in 467 µL TE
buffer. 30 µL of 10% SDS and 3 µL of 20 mg/mL Proteinase K (Fermentas, Sankt Leon-Rot, Germany)
was added to each tube and incubated for 1 h at 37 ◦C. An equal volume of phenol/chloroform
(phenol-chloroform-isoamyl alcohol mixture ratio 25:24:1, Sigma Aldrich, Arklow, Ireland) was added
and mixed well. Tubes were centrifuged, at ~18,042 g for 10 min (Eppendorf Centrifuge, 5417r,
Eppendorf UK Ltd., Stevenage, UK). The upper phase of each Eppendorf tube was aspirated to fresh
2 mL Eppendorf tubes, avoiding the interphase. 100 µL of 3M sodium acetate (NaOAc) pH 5.2 was
added to each tube and mixed well. 600 µL of isopropanol (Sigma Aldrich, Arklow, Ireland) was
added, mixed well, and incubated at room temperature for 15 min. Tubes were then centrifuged at
~18,042 g for 20 min. Supernatants were removed and discarded. DNA pellets were washed with cold
(4 ◦C) 70% EtOH. Tubes were centrifuged at ~18,042 g for 10 min. Ethanol was removed and discarded
and DNA pellets were allowed to air-dry. DNA was re-suspended in 1 mL TE buffer. 1 µL of RNase A
was added to the tubes, which were then incubated at 37 ◦C for 30 min. DNA was again purified by
phenol extraction. DNA was analysed by gel electrophoresis and quantified using a spectrophotometer
(NanoDrop ND-1000, Thermo Scientific, Gloucester, UK). The DNA solutions were stored at −20 ◦C.
3.4. 16S rRNA Gene Sequencing
16S rRNA genes were amplified by PCR using a Peltier Thermal Cycler PTC-200 PCR System (MJ
Research Inc., Waltham, MA, USA). Each PCR reaction comprised 1X reaction buffer, 0.2 mM dNTPs,
0.5 µM forward primer [27f (5′-AGAGTTTGATCMTGGCTCAG-3′)], 0.5 µM reverse primer [1492r
(5′-TACGGYTACCTTGTTACGACTT -3′)] [38], 1 U Taq polymerase (5 U/µL), 1.0 µL template DNA
(1–10 ng), sdH2O. PCR cycle conditions comprised initial denaturation at 95 ◦C for 3 min followed by
30 cycles of denaturation at 95 ◦C for 1 min, primer annealing at 50 ◦C for 1 min, extension at 72 ◦C for
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1 min followed by a final extension at 72 ◦C for 5 min. PCR products were analysed by electrophoresis
on 1% agarose gels. PCR amplicons were sequenced by capillary electrophoresis, single extension
sequencing (Macrogen Inc., Korea), using 3730xl DNA Analyser.
3.5. 16S rRNA Based Phylogenetic Analysis
Sequences were manually edited for quality using FinchTV 1.4.0 (Geospiza, Inc.; Seattle, WA,
USA; http://www.geospiza.com). Sequence alignment and tree construction were performed using
MEGA version 6 [39] (Arizona State University & Pennsylvania State University, USA, http://www.
megasoftware.net/). Alignment was performed with ClustalW [40] using the Maximum Parsimony
approach [41] and included bootstrap tests (n = 500). The evolutionary distances are in the units
of the number of base substitutions per site. All positions containing gaps and missing data were
eliminated from the datasets (complete deletion option). Reference sequences were downloaded from
the Ribosomal Database Project (release 11, update 4, 26 May 2015, https://rdp.cme.msu.edu/) [42].
3.6. Bioactivity Screening
Isolates were screened for antibacterial activities against a panel of clinically relevant
Gram negative [Escherichia coli NCIMB 12210 and Pseudomonas aeruginosa PAO1], Gram positive
[Bacillus spp.—B. subtilis 1E32, B. subtilis 1A40, B. cereus FPL1); Staphylococcus spp. (hVISA
[Heterogonous Vancomycin Intermediate Staphylococcus aureus 22900], MRSA [Methicillin Resistant
S. aureus ST544], VISA [Vancomycin Intermediate S. aureus 35403], S. aureus NCIMB 9518) and Listeria
monocytogenes F2365] and against the yeasts Candida spp. [C. glabrata CBS138 and C. albicans MY1055]
and the fungus Aspergillus fumigatus ATCC 46645 test strains using a deferred antagonism assay [43].
It should be noted that not all isolates were tested against all test strains. Only the results shown in
Table 1 were performed. Isolates were spotted to the centre of Petri dishes on SYP-SW agar and grown
until the colony reached 1–2 cm in diameter. Test strains were grown overnight in 5 mL LB broth,
shaking, 200 rpm until they reached an OD600nm 0.8. Test strains were then diluted 1:50 in LB soft
agar (0.7% agar—w/v). Inoculated soft agar was poured onto the surface of the plates containing the
isolates. Plates were incubated at 37 ◦C and examined the next day for zones of inhibition—clearance
zones in the growth of the test strain around the colony of the isolate.
3.7. Whole Genome Sequencing
For whole genome sequencing, mate pair libraries were prepared the using the Nextera XT DNA
Library Preparation Kit (Illumina, San Diego, CA, USA) according to the manufacturer’s instructions.
All libraries were sequenced in 250 bp paired read runs on the Illumina MiSeq platform. Reads were
trimmed for quality with Sickle (Available at https://github.com/najoshi/sickle) and Scythe (Available
at https://github.com/vsbuffalo/scythe).
3.8. Bioinformatic Methods
Genome assemblies were performed using SPAdes, version 3.1.1 using K-mer lengths of 21, 33,
55, 77, 81 and 91 [44]. Pan genome analysis was performed using Get Homologues [45]. Comparative
genomic methods were carried out on the following 25 genomes which included the 13 isolates from
Irish marine sponges presented here and the following 12 terrestrial Streptomyces spp. genomes from
the sequence databases: S. albus J1074, S. avermitilis MA46-80, S. bingchenggensis BCW-1, S. coelicolor
A3(2), S. davaoensis JCM 4913, S. fulvissimus DSM 40593, S. hygroscopicus subsp jingganggensis 5008,
S. griseus NBRC 13350, S. lividans, S. sirex AA-E, S. venezuelae ATCC 10712 and S. violaceusniger Tü4113.
Potential bioactive gene clusters were identified by searching the genomes with antiSMASH version 3
and parsed with R methods, R is a free software environment for statistical computing and graphics
(The R Project—available at https://www.r-project.org/). Pfam domains often represented within
these gene clusters were counted and graphed using R.
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4. Conclusions
Analysis of the draft genomes of 11 Streptomyces spp. isolated from a shallow water sponge and
an additional two isolated from deep sea sponges reveal the presence of highly abundant smBGCs.
Amongst the 485 gene clusters identified, the majority display little or no homology with known
smBGCs in the MIBiG database. The notably abundant PKS, NRPS, PKS/NRPS hybrid, bacteriocin
and lantipeptide gene clusters are of particular interest in the search for novel antibiotic families and
species in light of the worrisome trends in the occurrences of antimicrobial resistant human pathogens,
particularly so because many of these strains have effectively inhibited the growth of problematic
pathogenic strains (hVISA, MRSA) in plate screens.
Availability of data and material: The datasets generated during and/or analysed during
the current study are available in GenBank hosted by NCBI under the BioProject accession
PRJNA384120 (https://www.ncbi.nlm.nih.gov/bioproject/PRJNA384120/) with individual genome
accession codes NETW00000000, NETX00000000, NETY00000000, NETZ00000000, NEUA00000000,
NEUB00000000, NEUC00000000, NEUD00000000, NEUE00000000, NEUF00000000, NEUG00000000,
NEUH00000000, NEUI00000000.
Supplementary Materials: The following are available online at www.mdpi.com/1660-3397/16/2/67/s1,
Figure S1: Phylogenetic tree of deduced amino acid sequences of KS domains from PKS gene clusters from
Streptomyces spp.; Figure S2: Phylogenetic tree of deduced amino acid sequences of condensation starter domains
of NRPS gene clusters from Streptomyces spp.; Figure S3: Phylogenetic tree of deduced amino acid sequences of
condensation DCL domains NRPS gene clusters from Streptomyces spp.; Figure S4: Phylogenetic tree of deduced
amino acid sequences of condensation LCL domains from NRPS gene clusters from Streptomyces spp.; Figure
S5: Phylogenetic tree of deduced amino acid sequences of (A) epimerization domains and (B) heterocyclization
domains from NRPS gene clusters from Streptomyces spp.; Figure S6: Phylogenetic tree of deduced amino acid
sequences of IucA-IucC domains from PKS gene clusters from Streptomyces spp.; Figure S7: Phylogenetic tree
of deduced amino acid sequences of DUF692 domains from bacteriocin gene clusters from Streptomyces spp.;
Figure S8: Phylogenetic tree of deduced amino acid sequences of LanC-like domains from lantipeptide gene
clusters from Streptomyces spp.; Table S1: Taxonomy of Streptomyces spp. isolates using KRAKEN; Table S2:
Secondary metabolism biosynthetic gene clusters in the genome of Streptomyces sp. B188M101 as predicted
by antiSMASH; Table S3: Secondary metabolism biosynthetic gene clusters in the genome of Streptomyces sp.
B226SN101 as predicted by antiSMASH; Table S4: Secondary metabolism biosynthetic gene clusters in the
genome of Streptomyces sp. SM5 as predicted by antiSMASH; Table S5: Secondary metabolism biosynthetic gene
clusters in the genome of Streptomyces sp. SM10 as predicted by antiSMASH; Table S6: Secondary metabolism
biosynthetic gene clusters in the genome of Streptomyces sp. SM11 as predicted by antiSMASH; Table S7: Secondary
metabolism biosynthetic gene clusters in the genome of Streptomyces sp. SM12 as predicted by antiSMASH; Table
S8: Secondary metabolism biosynthetic gene clusters in the genome of Streptomyces sp. SM16 as predicted by
antiSMASH; Table S9: Secondary metabolism biosynthetic gene clusters in the genome of Streptomyces sp. SM17
as predicted by antiSMASH; Table S10: Secondary metabolism biosynthetic gene clusters in the genome of
Streptomyces sp. SM18 as predicted by antiSMASH; Table S11: Secondary metabolism biosynthetic gene clusters in
the genome of Streptomyces sp. SM1 as predicted by antiSMASH; Table S12: Secondary metabolism biosynthetic
gene clusters in the genome of Streptomyces sp. FMC008 as predicted by antiSMASH; Table S13: Secondary
metabolism biosynthetic gene clusters in the genome of Streptomyces sp. SM14 as predicted by antiSMASH;
Table S14: Secondary metabolism biosynthetic gene clusters in the genome of Streptomyces sp. SM9 as predicted
by antiSMASH.
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